TrialBritish journal of cancer2014

First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study.

J Feliu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.